MedTrace Logo

Myosfascial Trigger-Points and Effects on Neuromuscular Response

NCT03941054 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-05-07

No results posted yet for this study

Summary

The aim of this study is to analyze the effects of the treatment of the Myosfascial Trigger-Points detected in the gastrocnemius muscles on the neuromuscular response.

Conditions

  • Myofascial Trigger Point Pain

Interventions

OTHER

Pressure Release

Subjets receive digitopressure during 90 seconds for the treatment of the Myosfascial Trigger Points

Sponsors & Collaborators

  • Universitat Internacional de Catalunya

    lead OTHER

Principal Investigators

  • Albert Pérez-Bellmunt, PhD · Anatomy lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2019-06-07
Completion
2019-06-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941054 on ClinicalTrials.gov